Skip to content
healthcare.dev
Get a free key

Lanreotide Acetate

NDC 69097-870, lanreotide acetate, injection, from Cipla USA Inc..

Product NDC
69097-870
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215395
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-870 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANREOTIDE ACETATE120 mg/.5mL

Pharmacologic classes

Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]

Package NDCNDC-11Package
69097-870-67690970870671 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/11da176a-99bc-4ada-8b3f-6bd2b37a6313

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69097-870

Use it

Look up 69097-870 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-870 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-870. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.